TradingMarkets 7 Stocks You Need To Know For Wednesday

• January 10, 2006
• Brice Wightman

Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) was in-line and guided in-line. 
Rituxin and Herceptin sales were greater than expected.
Avastin sales were less than expected. DNA‘s
Power Rating
is
6.

Apple
(
AAPL |
Quote |
Chart |
News |
PowerRating)
said its new computers will use Intel
(
INTC |
Quote |
Chart |
News |
PowerRating)
chips. INTCs
Power Rating
is
5.

Power Rating is
5.

Protein Design Labs
(
PDLI |
Quote |
Chart |
News |
PowerRating) may be in focus as it receives revenue from Avastin and Herceptin.
PDLIs
Power Rating
is

4.

Komag
(
KOMG |
Quote |
Chart |
News |
PowerRating) raised revenue guidance for the fourth quarter.
KOMG‘s
Power Rating
is
3.

Perrigo

(
PRGO |
Quote |
Chart |
News |
PowerRating) said it received FDA approval for
Desoximetasone.
PRGO‘s
Power Rating
is
5.

Cray

 
(
CRAY |
Quote |
Chart |
News |
PowerRating) said fiscal 2005 would be above consensus. 

How is your favorite stock Power Rated? 
Click here.

Brice Wightman